On 5/16 at the #STATBreakthrough Summit West, Vijay Pande will join insitro’s Daphne Koller and Novartis Institute For Biomedical Research’s Derek Lowe for a panel moderated by STAT’ Matthew Herper on setting expectations for AI in drug development. More 👇

#ICYMI: insitro CEO and founder Daphne Koller was at Milken Institute’s #MIGlobal Conference to discuss the “golden age in medicine," #AI’s promise to accelerate the development of new treatments & cures & innovations that hope to revolutionize healthcare. milkeninstitute.org/panel/15449/pl…

Join insitro founder and CEO, Daphne Koller as she joins Derek Lowe and insitro board member Vijay Pande for a panel on expectations for #AI in drug development at the STAT #STATBreakthrough Summit West at 4:45 p.m. PT today. statnews.com/2024-breakthro…

insitro founder and CEO Daphne Koller sat down with CPP Investments to share insights from building insitro & the evolution of #AI, how we operate within a unique ecosystem & the solutions we aim to achieve through transformative new medicines. cppinvestments.com/insight-instit…

AI can help advance drug development. During #STATBreakthrough Summit in San Francisco, experts talked about what's realistic and what's hype. trib.al/R31gS8X

.Ron Leuty featured #AI & #machinelearning visionary Emily Fox's appointment this spring & more on how we bring together tech & biology to drive #drugdiscovery that will transform treatment for patients in a dialogue with Emily & Daphne Koller. bizjournals.com/sanfrancisco/n…

June 2nd, insitro CEO & founder Daphne Koller will join the #WorldScienceFestival for the “Fundamental Science in the Age of Artificial Intelligence” panel, exploring the profound role #AI could play in taking human understanding to the next level. worldsciencefestival.com/programs/funda…

We’re looking forward to attending Goldman Sachs' 45th Annual Global #Healthcare Conference next week where our founder and CEO, Daphne Koller, will participate in a fireside chat on Monday, June 10.

insitro Sr. Director of Intl. Corporate Development Dr Claire Bloomfield will be @ #HLTHEurope for “Ghosts in the machine: Empowering healthcare to capitalize on GenAI,” on June 19. Join as she speaks on harnessing the power of #genAI in healthcare & #drugdiscovery. europe.hlth.com

We're excited to welcome Gwynne Oosterbaan as VP, Communications and External Affairs. With more than 20 years of experience, including 9 years at GSK, her expertise will be invaluable as we push to revolutionize drug discovery & development using AI/ML & data-driven approaches.

insitro Director, Oligonucleotide Therapeutics Arijit Bhowmick joined Nucleic Acid Insights to discuss all things oligonucleotide therapeutics, with a focus on the role #AI & #ML play in creating better drugs for patients. Check it out. ⤵️ insights.bio/nucleic-acid-i…

Wow! A big insitro welcome to our new CTOO, Jennitte Stevens! Her deep background in process development with 20+ years’ experience in therapeutic discovery, design & development will be pivotal to insitro as we take the next steps to advance our lead programs towards the clinic.

Terrific listening to our CEO Daphne Koller and Jeffrey G. Reid of Regeneron’s Genetic Center compare notes on #AI, genetics, #DEI, and talent pathways. They reinforced the urgent task of improving medicines for patients on Regeneron's new podcast, "The Nucleus."

Our founder & CEO, Daphne Koller, has been named to TIME’s 2024 #TIME100AI list! We are proud to see our founder recognized for her visionary leadership on AI in #drugdiscovery, working towards the aspiration of making a healthier world. Read more: time.com/7012718/daphne…

This summer, we hosted 27 students from BS, MS and PhD programs who tackled cutting-edge ML-driven drug discovery challenges. From gene behavior to single-cell analysis, they pushed boundaries & brought fresh energy. Thanks to all for an inspiring season of innovation. 🔬

Big thank you to Reid Hoffman for hosting insitro founder & CEO, Daphne Koller on a recent edition of the Possible podcast. From the importance of uncovering new therapeutic hypotheses to the transformative power of biology at scale & #machinelearning, this conversation is chock

It was a great crowd at last week’s Biocom California Converge Meet-Up event! Our director, software engineering, Christoph Klein, joined industry colleagues for an evening of networking and sharing a closer look at the platform tools our team is inventing and scaling at our labs at

Can #machinelearning & #AI reinvent #drugdiscovery? Join insitro CEO & founder Daphne Koller for a keynote at the #FierceBiotechSummit as she shares how #ML is driving breakthroughs in discovery. Join us: fiercebiotechsummit.com/fiercebiotechs…